Global HPV Testing Market 2014-2018

Global HPV Testing Market 2014-2018

Category : Diagnostic and Biotech
Published On : January  2014
Pages : 46

------------ Or -------------

TechNavio's analysts forecast the Global HPV Testing market to grow at a CAGR of 19.43 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in risk of the number of people prone to HPV. The Global HPV Testing market has also been witnessing the increase in mergers & acquisitions. However, the limited number of health clinics could pose a challenge to the growth of this market. 
TechNavio's report, the Global HPV Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global HPV Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space are bioMérieux SA., Hologic Inc., Roche Diagnostics Ltd., and Qiagen N.V.
Other vendors mentioned in the report are Abbott Molecular Inc., Arbor Vita Corp., Becton, Dickinson and Co., IncellDx Inc., Quest Diagnostics Inc., Trovagene Inc., and Ventana Medical Systems Inc.
Key questions answered in this report: 
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Geographical Segmentation

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape

15.1 Competitive Scenario

15.1.1 Key News

15.1.2 Mergers and Acquisitions

15.2 Other Prominent Vendors

16. Key Vendor Analysis

16.1 Qiagen N.V.

16.1.1 Business Overview

16.1.2 Key Information

16.1.3 SWOT Analysis

16.2 Hologic Inc.

16.2.1 Business Overview

16.2.2 Business Segmentation

16.2.3 Key Information

16.2.4 SWOT Analysis

16.3 Roche Diagnostics Ltd

16.3.1 Business Overview

16.3.2 Business Segmentation

16.3.3 Key Information

16.3.4 SWOT Analysis

16.4 bioMérieux SA.

16.4.1 Business Overview

16.4.2 Key Information

16.4.3 SWOT Analysis

17. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global HPV Testing Market 2013–2018 (US$ million)

Exhibit 3: Global HPV Testing Market by Geography 2013 (percent)

Exhibit 4: Business Segmentation of Hologic Inc.

Exhibit 5: Business Segmentation of Roche Diagnostics Ltd.

Enquiry Before Buy